Pharmacokinetics and safety profiles of beinaglutide injection, a recombinant human GLP-1, in adults with overweight/obesity: results from a phase I clinical trial

• Main Authors: Pingping Lin (Author), Chengqian Li (Author), Yanping Liu (Author), Feifei Sun (Author), Tsung-Han Hsieh (Author), Lin Zhang (Author), Yaping Ma (Author), Xiaomeng Gao (Author), Qing Yu (Author), Yu Cao (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BackgroundBeinaglutide, whose active ingredient is rhGLP-1, has been widely used as a pharmacological therapy for T2DM. We explored the safety and pharmacokinetics of beinaglutide in Chinese overweight/obese volunteers to lay a foundation for clinical applications of beinaglutide as an anti-obesity...